Related references
Note: Only part of the references are listed.Intense PSMA-expression using Ga-68-PSMA PET/CT in a paravertebral schwannoma mimicking prostate cancer metastasis
Christoph Rischpler et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Dosimetry for Lu-177-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer
Andreas Delker et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Detection of F-18-FDG PET/CT Occult Lesions With F-18-DCFPyL PET/CT in a Patient With Metastatic Renal Cell Carcinoma
Steven P. Rowe et al.
CLINICAL NUCLEAR MEDICINE (2016)
I.5-T multiparametric MRI using PI-RADS: a region by region analysis to localize the index-tumor of prostate cancer in patients undergoing prostatectomy
Lars A. Reisaeter et al.
ACTA RADIOLOGICA (2015)
Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted 18F-DCFPyL PET/CT
Steven P. Rowe et al.
ANNALS OF NUCLEAR MEDICINE (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Detection of Brain Metastasis With 68Ga-Labeled PSMA Ligand PET/CT A Novel Radiotracer for Imaging of Prostate Carcinoma
Partha Sarathi Chakraborty et al.
CLINICAL NUCLEAR MEDICINE (2015)
First evidence of PSMA expression in differentiated thyroid cancer using [68Ga]PSMA-HBED-CC PET/CT
Frederik A. Verburg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Magnetic Resonance Imaging-Transectal Ultrasound Image-fusion Biopsies Accurately Characterize the Index Tumor: Correlation with Step-sectioned Radical Prostatectomy Specimens in 135 Patients
Eduard Baco et al.
EUROPEAN UROLOGY (2015)
Prostate-specific Membrane Antigen-radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer
Tobias Maurer et al.
EUROPEAN UROLOGY (2015)
Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review
Massimo Valerio et al.
EUROPEAN UROLOGY (2015)
217 PSMA-PET/MRI-guided transrectal fusion biopsy for the detection of prostate cancer
E. Storz et al.
EUROPEAN UROLOGY SUPPLEMENTS (2015)
18F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer
Steven P. Rowe et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions
Ali Afshar-Oromieh et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
Matthias Eiber et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer
Martina Benesova et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
Martina Weineisen et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Radiofluorination of PSMA-HBED via Al18F2+ Chelation and Biological Evaluations In Vitro
Noeen Malik et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer
Markus Dietlein et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
Initial Evaluation of [F-18]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer
Zsolt Szabo et al.
MOLECULAR IMAGING AND BIOLOGY (2015)
Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging
Levent Kabasakal et al.
NUCLEAR MEDICINE COMMUNICATIONS (2015)
Multimodal image-guided prostate fusion biopsy based on automatic deformable registration
Oliver Zettinig et al.
INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY (2015)
[111In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery
Margret Schottelius et al.
EJNMMI RESEARCH (2015)
Ga-68-PSMA PET/MR with multimodality image analysis for primary prostate cancer
Matthias Eiber et al.
ABDOMINAL IMAGING (2015)
[68Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice
Thomas Krohn et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
In vivo visualization of prostate-specific membrane antigen in glioblastoma
Johannes Schwenck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Comparative Effectiveness of [18F]-Fluorocholine PET-CT and Pelvic MRI With Diffusion-Weighted Imaging for Staging in Patients With High-Risk Prostate Cancer
Jean-Baptiste Pinaquy et al.
PROSTATE (2015)
A Modular Strategy to Prepare Multivalent Inhibitors of Prostate-Specific Membrane Antigen (PSMA)
Sangeeta Ray Banerjee et al.
Oncotarget (2015)
[11C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomy
Martin C. Schumacher et al.
SCANDINAVIAN JOURNAL OF UROLOGY (2015)
Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy
Lars Schimmoeller et al.
EUROPEAN RADIOLOGY (2014)
Early Salvage Radiotherapy Following Radical Prostatectomy
David Pfister et al.
EUROPEAN UROLOGY (2014)
Positron emission tomography/magnetic resonance imaging with 68Gallium-labeled ligand of prostate-specific membrane antigen: Promising novel option in prostate cancer imaging?
Tobias Maurer et al.
INTERNATIONAL JOURNAL OF UROLOGY (2014)
Pharmacokinetics and PET imaging properties of two recombinant anti-PSMA antibody fragments in comparison to their parental antibody
Stefan Wiehr et al.
PROSTATE (2014)
Performance of multiparametric magnetic resonance imaging in the evaluation and management of clinically low-risk prostate cancer
Seyed Saeid Dianat et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
18F-fluorocholine PET/CT compared with extended pelvic lymph node dissection in high-risk prostate cancer
H. Kjolhede et al.
WORLD JOURNAL OF UROLOGY (2014)
Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer
Martina Weineisen et al.
EJNMMI RESEARCH (2014)
Synthesis and SAR of 99mTc/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates
Genliang Lu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Application of 11C-acetate positron-emission tomography (PET) imaging in prostate cancer: systematic review and meta-analysis of the literature
Beheshti Mohsen et al.
BJU INTERNATIONAL (2013)
PET Imaging in Prostate Cancer: Focus on Prostate-Specific Membrane Antigen
Ronnie C. Mease et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
A. Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
PET/MR in prostate cancer: technical aspects and potential diagnostic value
Michael Souvatzoglou et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations
Hossein Jadvar
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
11C-Choline PET/CT and PSA kinetics
Paolo Castellucci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
PET/MRI with a 68Ga-PSMA ligand for the detection of prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients
Claudia Brogsitter et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer
Michael Souvatzoglou et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Utility of Choline Positron Emission Tomography/Computed Tomography for Lymph Node Involvement Identification in Intermediate- to High-risk Prostate Cancer: A Systematic Literature Review and Meta-analysis
Laura Evangelista et al.
EUROPEAN UROLOGY (2013)
The Role of 11C-Choline and 18F-Fluorocholine Positron Emission Tomography (PET) and PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis
Martin H. Umbehr et al.
EUROPEAN UROLOGY (2013)
Transition Zone Prostate Cancer: Detection and Localization with 3-T Multiparametric MR Imaging
Caroline M. A. Hoeks et al.
RADIOLOGY (2013)
Diffusion-Weighted MRI in the Detection of Prostate Cancer: Meta-Analysis
Cher Heng Tan et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2012)
The Clinical Value of Diffusion-Weighted Imaging in Combination With T2-Weighted Imaging in Diagnosing Prostate Carcinoma: A Systematic Review and Meta-Analysis
Lian-Ming Wu et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2012)
68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
Matthias Eder et al.
BIOCONJUGATE CHEMISTRY (2012)
Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer
Nitin K. Yerram et al.
BJU INTERNATIONAL (2012)
Relationship between PSA kinetics and [18F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy
Vera Graute et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH
A. Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
ESUR prostate MR guidelines 2012
Jelle O. Barentsz et al.
EUROPEAN RADIOLOGY (2012)
Can Whole-body Magnetic Resonance Imaging with Diffusion-weighted Imaging Replace Tc 99m Bone Scanning and Computed Tomography for Single-step Detection of Metastases in Patients with High-risk Prostate Cancer?
Frederic E. Lecouvet et al.
EUROPEAN UROLOGY (2012)
The Timing of Salvage Radiotherapy After Radical Prostatectomy: A Systematic Review
Christopher R. King
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer
Yu-Jen Chen et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2012)
Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer
Steve Y. Cho et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Diffusion-Weighted and Dynamic Contrast-Enhanced MRI of Prostate Cancer: Correlation of Quantitative MR Parameters With Gleason Score and Tumor Angiogenesis
Aytekin Oto et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
The Sensitivity of [11C]Choline PET/CT to Localize Prostate Cancer Depends on the Tumor Configuration
Michael Souvatzoglou et al.
CLINICAL CANCER RESEARCH (2011)
2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
Ying Chen et al.
CLINICAL CANCER RESEARCH (2011)
Is there a role for C-11-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase < 1.5 ng/ml?
Paolo Castellucci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature
Mary K. Samplaski et al.
MODERN PATHOLOGY (2011)
Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen
Michael J. Evans et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies
Haofan Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Anti-Prostate-Specific Membrane Antigen-Based Radioimmunotherapy for Prostate Cancer
Scott T. Tagawa et al.
CANCER (2010)
Value of Magnetic Resonance Spectroscopy Imaging and Dynamic Contrast-Enhanced Imaging for Detecting Prostate Cancer Foci in Men With Prior Negative Biopsy
Alessandro Sciarra et al.
CLINICAL CANCER RESEARCH (2010)
A Systematic Review of the Role of Imaging before Salvage Radiotherapy for Post-prostatectomy Biochemical Recurrence
M. J. Beresford et al.
CLINICAL ONCOLOGY (2010)
The Renaissance of the 68Ge/68Ga Radionuclide Generator Initiates New Developments in 68Ga Radiopharmaceutical Chemistry
Frank Roesch et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Imaging of prostate cancer local recurrences: why and how?
Olivier Rouviere et al.
EUROPEAN RADIOLOGY (2010)
Preliminary Results for Characterization of Pelvic Lymph Nodes in Patients With Prostate Cancer by Diffusion-Weighted MR-Imaging
Matthias Eiber et al.
INVESTIGATIVE RADIOLOGY (2010)
89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
Jason P. Holland et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
18F Choline PET/CT in the Preoperative Staging of Prostate Cancer in Patients with Intermediate or High Risk of Extracapsular Disease: A Prospective Study of 130 Patients
Mohsen Beheshti et al.
RADIOLOGY (2010)
Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer
Shawn M. Hillier et al.
CANCER RESEARCH (2009)
Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers
Michael C. Haffner et al.
HUMAN PATHOLOGY (2009)
A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer
K. P. Maresca et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
PET Imaging of Prostate Cancer Xenografts with a Highly Specific Antibody against the Prostate-Specific Membrane Antigen
Ursula Elsaesser-Beile et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted 99mTc-Radioimaging Agents
Sumith A. Kularatne et al.
MOLECULAR PHARMACEUTICS (2009)
Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis
Sebastian Mannweiler et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Prostate Cancer: Apparent Diffusion Coefficient Map with T2-weighted Images for Detection-A Multireader Study
Hyun Kyung Lim et al.
RADIOLOGY (2009)
Dynamic Contrast-enhanced-magnetic Resonance Imaging Evaluation of Intraprostatic Prostate Cancer: Correlation with Radical Prostatectomy Specimens
Philippe Puech et al.
UROLOGY (2009)
Comparison between malignant and benign abdominal lymph nodes on diffusion-weighted imaging
E. Isin Akduman et al.
ACADEMIC RADIOLOGY (2008)
N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC:: A new imaging probe for prostate cancer
Ronnie C. Mease et al.
CLINICAL CANCER RESEARCH (2008)
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer:: a meta-analysis
A. M. Hovels et al.
CLINICAL RADIOLOGY (2008)
Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: Early experience
Jeong Kon Kim et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2008)
MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer:: a prospective multicohort study
Roel A. M. Heesakkers et al.
LANCET ONCOLOGY (2008)
The detection rate of [C-11]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer
B. J. Krause et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging
G. Manenti et al.
RADIOLOGIA MEDICA (2006)
Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging
Jurgen J. Fuetterer et al.
RADIOLOGY (2006)
Tumour markers for managing men who present with metastatic prostate cancer and serum prostate-specific antigen levels of <10 ng/mL
AJ Birtle et al.
BJU INTERNATIONAL (2005)
2-[18F]Fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy
H Schöder et al.
CLINICAL CANCER RESEARCH (2005)
Radiolabeled small-molecule ligands for prostate-specific membrane antigen:: In vivo imaging in experimental models of prostate cancer
CA Foss et al.
CLINICAL CANCER RESEARCH (2005)
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer
A Ghosh et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy
N Schülke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Pathological and molecular aspects of prostate cancer
AM DeMarzo et al.
LANCET (2003)
Prostate adenocarcinoma presenting with inguinal lymphadenopathy
E Huang et al.
UROLOGY (2003)
A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen
SA Rajasekaran et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging
B Issa
JOURNAL OF MAGNETIC RESONANCE IMAGING (2002)
Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen
SS Chang et al.
UROLOGY (2001)
Experience with carbon-11 choline positron emission tomography in prostate carcinoma
J Kotzerke et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)